The global cold pain therapy market size was valued at USD 2.52 billion in 2025 and is projected to grow from USD 2.64 billion in 2026 to USD 3.83 billion by 2034, registering a CAGR of 4.77% during the forecast period (2026–2034). North America dominated the cold pain therapy market with a share of 38.80% in 2025.
Cold pain therapy refers to the therapeutic application of cold to temporarily reduce pain, swelling, and inflammation following injuries, surgery, or other conditions. Cold therapy includes ice packs, water circulating cooling devices, and other localized cooling systems used to deliver controlled cold to targeted areas of the body. Cold pain therapy devices are tracked under HSN Code 9019 (mechano-therapy appliances and other therapeutic apparatus) and SIC Code 3845 (electromedical and electrotherapeutic apparatus).
The cold pain therapy market demand is supported by the incidence of sports injuries, musculoskeletal pain, and post-surgical pain, along with the adoption of non-invasive pain management approaches. Healthcare providers and patients are increasingly using localized cooling and cold compression devices to help manage pain, swelling, and inflammation, contributing to cold pain therapy market growth.
• 2025 Market Size: USD 2.52 Billion• 2026 Market Size: USD 2.64 Billion• 2034 Projected Market Size: USD 3.83 Billion• Forecast Period: 2026–2034• Base Year: 2025• Market CAGR (2026–2034): 4.77%
• Largest Regional Market (2025): North America• North America Market Share (2025): 38.80%• Fastest-growing Region: Asia Pacific• Asia Pacific CAGR (2026–2034): 6.55%
By Product Type
• Leading Segment: Gels, Ointments & Creams• Market Share in 2025: 28.5%
By Application
• Fastest-growing Segment: Sports Medicine• CAGR: 5.46% (2026–2034)
By Distribution Channel
• Leading Segment: Drug Stores & Retail Pharmacies• Market Share in 2025: 47.5%
Download a Free Sample To learn more about this report,
Integration of Cold Therapy with Pneumatic Compression
Cold therapy systems are combining controlled cooling with pneumatic compression to manage pain and swelling together. These devices apply cold while providing adjustable pressure around the treated area. This combination strengthens multi function treatment options for recovery and pain management.
Expansion of Portable Cold Therapy Systems
The cold pain therapy market analysis shows that the devices are becoming smaller and easier to transport for use outside hospitals and clinics. Portable systems can support treatment at home, during travel, or during rehabilitation without requiring fixed equipment. This shift broadens access to convenient cold pain therapy.
Supply chain disruptions are expected to have a moderate impact on the cold pain therapy market share, as dependence on electronic components, sensors, tubing, and specialized medical device parts can create procurement delays and higher manufacturing costs. The market is likely to follow a K-shaped recovery pattern, as simple cold therapy products can return to normal supply faster, while advanced cold and compression systems can recover more slowly because of greater component and manufacturing requirements. The market is expected to grow at a CAGR of 4.77%, but supply chain constraints could approximately lower this by 0.3 percentage points, resulting in short-term growth of around 4.47%. As supply conditions normalize through broader component sourcing, improved availability of pumps and electronics, stronger supplier networks, and more reliable medical device logistics, cold pain therapy market growth is expected to gradually return to 4.77%.
The cold pain therapy market forecasts strategic investment activity driven by advanced cryotherapy devices, portable cold-compression systems, targeted temperature-control technologies, non-invasive pain management solutions, and growing demand for post-surgical and sports-injury recovery treatments. In July 2025, Region Västerbotten and Cancercentrum Öppenvård received approximately USD 0.13 million in funding from Vinnova for the P-Cool project to evaluate and implement a novel cooling system designed to reduce chemotherapy-induced peripheral neuropathy and associated pain.
High Orthopedic Procedure Activity and Sports Injury Burden Drive Market
High orthopedic procedure volumes increase the need for post-surgical recovery support, particularly for swelling and localized discomfort after joint and soft tissue procedures. Orthopedic care can use cooling as part of recovery protocols to manage inflammation and support comfort during early rehabilitation. This creates recurring applications for therapeutic cooling in clinical recovery settings.
A higher incidence of sports injuries such as sprains, strains, and soft tissue trauma creates additional applications for cold pain therapy. Physical therapy and rehabilitation programs can use cooling to support early injury management and inflammation management. Broader sports recovery activity therefore supports use of cold therapy solutions.
Limited Reimbursement Coverage and Vascular Eligibility Issues Restrict Adoption
Limited reimbursement coverage for cold pain therapy can increase out-of-pocket treatment costs for patients and reduce provider willingness to include cooling based care in treatment plans. This can restrict use of cold therapy devices within some rehabilitation and pain management programs.
Cold induced vasoconstriction can limit the use of cryotherapy in patients with certain circulation disorders. These clinical restrictions can narrow the eligible patient pool for non-invasive pain relief and cold compression therapy.
Development of Sensor Guided Cooling and Flexible Equipment Access Offer Growth Opportunities
Sensor guided cold therapy devices can monitor treatment area temperature and help control cooling intensity during therapy. Manufacturers can combine temperature feedback with defined treatment settings to improve control during therapeutic cooling and inflammation management. This creates a differentiated product opportunity for clinical and rehabilitation use.
Rental and subscription models can provide temporary access to cold therapy devices for patients recovering after procedures or managing short term injuries. Providers can offer equipment, fitting accessories, and support for a defined treatment period, reducing the need for full equipment purchase. This creates a recurring service model for orthopedic care and home recovery.
Gaps in Protocol Standardization and Alternative Pain Therapy Competition Hinders Growth
Differences in cooling temperature, treatment duration, and application frequency can make cold compression therapy less consistent across rehabilitation and orthopedic settings. Such variation can complicate the use of ice packs and other cooling methods within standardized physical therapy programs.
Alternative non invasive therapies such as electrotherapy and therapeutic ultrasound can compete with cold treatment for use in pain management programs. Broader availability of these treatment options can make it harder for cold therapy providers to strengthen their position across rehabilitation services.
The gels, ointments & creams segment accounted for a share of 28.5% in 2025, supported by their ease of application and broad availability for localized pain relief. Their suitability for routine treatment of muscle and joint discomfort supports consistent consumer use.
The motorized devices segment is expected to grow at a CAGR of 5.72% during the forecast period, driven by increasing demand for controlled cold therapy and convenient non drug based pain management. Motorized systems can provide consistent cooling with adjustable treatment settings, supporting use in home and clinical care.
Request Customizationto receive a tailored report.
The sports medicine segment accounted for a share of 29.4% in 2025, owing to the frequent use of cold therapy for managing muscle soreness, minor injuries, and inflammation associated with physical activity. Its routine application in athletic recovery supports strong demand for cold pain therapy products.
The post-operative therapies segment is expected to grow at a CAGR of 4.91% during the forecast period, fueled by the use of cold therapy to manage pain and swelling following surgical procedures.
The drug stores & retail pharmacies segment accounted for a share of 47.5% in 2025 due to broad accessibility and established role in distributing topical pain relief products and cold therapy solutions. Convenient local availability supports frequent purchases for pain management.
The e-commerce segment is expected to grow at a CAGR of 6.18% during the forecast period, propelled by the preference for home delivery and convenient access to cold pain therapy products. Online platforms also provide consumers with a wider selection of topical products and therapy devices.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by High Volume of Injury-related Treatment Needs
The North America cold pain therapy market accounted for the largest regional share of 38.80% in 2025, supported by expanding use of cold compression systems.
The U.S. market is driven by increasing adoption of cold compression therapy devices for pain and swelling management. In August 2026, the FDA cleared the ManaCold Compression System for physical medicine, adding to the regulated base of powered cold compression devices used for therapeutic cooling.
The Canada market benefits from a high volume of injury related treatment needs across emergency and hospital settings. From 2025 to 2026, Canada recorded more than 15.6 million unscheduled emergency department visits, with injuries remaining a major contributor to emergency care demand, supporting the need for non invasive pain and swelling management therapies.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Fueled by Focus on Sports Injury Care and Expanding Physiotherapy Equipment Demand
The Asia Pacific cold pain therapy market is expected to grow at a CAGR of 6.55% during the forecast period, showcasing the fastest-growing regional growth.
The Japan market is led by research on post-operative cooling devices for orthopedic care. A 2026 clinical study registered with Japan’s Clinical Trials Registry is evaluating an improved cooling therapy device following total knee replacement, assessing its safety and effectiveness for postoperative recovery.
The China market benefits from the established use of instant cooling products for sports injuries. For instance, Shijiazhuang Sports Bureau uses a broad range of cold sprays and instant ice packs for treating pain and swelling associated with muscle strains, sprains, and bruises among athletes.
The India cold pain therapy market is supported by the inclusion of cryotherapy within physiotherapy equipment requirements. The Ministry of Health and Family Welfare’s medical equipment procurement framework lists cryotherapy equipment as a standard item for physiotherapy departments, alongside therapeutic ultrasound and other treatment systems.
Europe: Growth Supported by Established Guidelines for Cooling Therapy and Investments in Accessible Care Approach
The Europe cold pain therapy market is expected to grow at a CAGR of 4.18% during the forecast period due to the use of medical cryotherapy for chronic pain and targeted cooling for joint swelling management.
The NHS 10-Year Health Plan is shifting care toward community and preventive services. The national rollout of an MSK programme received over USD 3 million in government investment to expand access to treatment for joint and muscle conditions, supporting future demand for non-invasive pain-management approaches such as cold therapy.
The German market benefits from established guidelines for cooling therapy for acute joint inflammation. For instance, the German Federal Ministry of Health’s health portal recommends ice or cold packs for muscle strains to reduce pain and swelling, with repeated applications of 10 to 20 minutes.
Latin America: Growth Shaped by Presence of Rehabilitation Units
The Latin America cold pain therapy market is expected to grow at a CAGR of 4.71% during the forecast period, supported by wider availability of regulated cold therapy accessories and targeted cryotherapy solutions. Mexico’s IMSS reported that it operates 199 rehabilitation units nationwide, with physical therapists treating conditions involving the shoulder, spine, knee, and ankle, while the government’s rehabilitation model. Federal investment programs in Brazil support the expansion and equipment of specialized rehabilitation centers, strengthening the future treatment infrastructure for non-invasive pain-management therapies.
Middle East & Africa: Growth Driven by Expansion of Whole Body Cryotherapy Applications
The Middle East and Africa cold pain therapy market is expected to grow at a CAGR of 4.95% during the forecast period, supported by expanding whole body cryotherapy applications and formal coverage of cold therapy appliances. In the UAE, the Olympic and Sports Science Centre lists whole body recovery technologies, including cold therapy as part of its treatment and recovery services. In South Africa, the Government Employees Medical Scheme lists multiple hot and cold therapy appliances, including instant ice packs, therapy wraps, and controlled temperature cuffs, within its medical and surgical appliance formulary.
The cold pain therapy market competitive landscape is moderately concentrated, with a mix of orthopedic device manufacturers, rehabilitation and recovery equipment companies, sports medicine providers, and therapeutic device manufacturers. Key players such as Breg, Inc., Enovis Corporation, Avanos Medical, Inc., Ossur, and Arthrex, Inc. are collectively estimated to account for approximately 25–30% of the global cold pain therapy market share.
Established participants compete primarily through temperature control, device reliability, clinical evidence, ergonomic design, and distribution capabilities. Emerging, niche, and regional companies in the cold pain therapy market ecosystem compete through wearable devices, battery-powered products, cost-efficient designs, and patient-focused recovery solutions.
July 2026: Channel Medsystems received FDA approval for a PMA supplement for the Cerene Cryotherapy Device.
April 2026: Chengdu Cryo-Push Medical Technology received FDA clearance for the A02-C-032 Hot and Cold Compression System (K252386), a Class II therapeutic device combining cold, heat and compression to reduce pain, edema and swelling associated with post-surgical and acute injuries.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Cochlear Implants Market Size, Share, Growth, Forecast, 2034
Closed-Loop Spinal Cord Stimulation Device Market Size, Share, 2034
Artificial Organs Market Size, Share, Growth, Forecast, 2034
Automated External Defibrillators Market Size, Share, Growth, 2034
Brain Monitoring Market Size, Share, Growth, Forecast, 2034
Breathwork Therapy Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com